LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • IDEAYA Biosciences Announces FDA IND Clearance For Phase 1 Trial Of IDE034 In Multiple Solid Tumors 12/1/2025 6:10:35 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 11/28/2025 6:01:55 AM
  • IDEAYA Biosciences 9-month Loss Per Share Narrows To $0.34 From $1.81 Last Year 11/4/2025 6:09:46 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 10/31/2025 6:08:19 AM
  • IDEAYA Biosciences Presents Positive Clinical Data From Their Ongoing Phase 2 OptimUM-09 Trial At ESMO 2025 10/20/2025 6:39:30 AM
  • IDEAYA Biosciences Presents Phase 2 OptimUM-01 Trial At 2025 Society For Melanoma Research Congress 10/20/2025 6:02:50 AM
  • IDEAYA Announces Positive Data From Phase 1/2 Trial Of IDE397 And Trodelvy In MTAP-Deletion Urothelial Cancer 9/8/2025 8:10:30 AM
  • IDEAYA Biosciences Announces Positive Phase 2 OptimUM-09 Trial In Neoadjuvant Setting Of Primary Uveal Melanoma 9/8/2025 6:07:35 AM
  • IDEAYA Biosciences And Hengrui Pharma Present Positive Phase 1 Data For IDE849 In Small Cell Lung Cancer 9/7/2025 12:04:58 PM
  • IDEAYA Biosciences Enrolls First-Patient-In For Phase 1/2 Combination Trial Of IDE397 And Trodelvy 9/4/2025 6:04:17 AM
  • IDEAYA Biosciences Announces IND Submission For IDE892 For MTAP-Deletion Solid Tumors 9/3/2025 6:30:42 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap